Featured Stories
Lisa Seifman to Speak at Bloomberg 's Global Credit Forum 2026 - London
NEW YORK, Nov. 18 [Category: BizLaw/Legal] -- Cahill Gordon and Reindel, a law firm, posted the following news:
* * *
Lisa Seifman to Speak at Bloomberg 's Global Credit Forum 2026 - London
*
Cahill partner Lisa Seifman, co-chair of the firm's Digital Infrastructure Finance practice group, will speak on the panel "Financing the AI revolution" at Bloomberg's Global Credit Forum 2026.
Lisa will join a panel of industry leaders, including Ben Richardson (CoreWeave), Eleanor Duncan (Bloomberg News), and Roald Nashi (Kirkland & Ellis LLP).
Hosted by Bloomberg News, Bloomberg Intelligence, and
... Show Full Article
NEW YORK, Nov. 18 [Category: BizLaw/Legal] -- Cahill Gordon and Reindel, a law firm, posted the following news:
* * *
Lisa Seifman to Speak at Bloomberg 's Global Credit Forum 2026 - London
*
Cahill partner Lisa Seifman, co-chair of the firm's Digital Infrastructure Finance practice group, will speak on the panel "Financing the AI revolution" at Bloomberg's Global Credit Forum 2026.
Lisa will join a panel of industry leaders, including Ben Richardson (CoreWeave), Eleanor Duncan (Bloomberg News), and Roald Nashi (Kirkland & Ellis LLP).
Hosted by Bloomberg News, Bloomberg Intelligence, andBloomberg Television, the Global Credit Forum brings together some of the most influential voices in the credit industry. Together the panelists will explore where debt markets go from here, at a time when a historic debt-fueled race to develop artificial intelligence is coinciding with a growing list of geopolitical headwinds.
To learn more about this, click here.
***
Original text here: https://www.cahill.com/news/events/2026-11-18-lisa-seifman-to-speak-at-bloombergs-global-credit-forum-2026-london
UCLA Researchers Discover New Approach for Treating Autism and Conditions Caused by a Single Faulty Gene Copy
LOS ANGELES, California, Nov. 14 (TNSjou) -- The UCLA Health issued the following news release:
* * *
UCLA researchers discover new approach for treating autism and conditions caused by a single faulty gene copy
Early-stage study in human cell models points to a possible new approach for conditions caused by a single faulty gene copy
November 13, 2026
Researchers at UCLA Health have shown in lab-grown human brain cells that boosting the activity of a healthy gene copy can offset the effects of a mutation linked to autism.
The findings (https://www.nature.com/articles/s41593-026-02504-9?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20261113&utm_content=10.1038/s41593-026-02504-9),
... Show Full Article
LOS ANGELES, California, Nov. 14 (TNSjou) -- The UCLA Health issued the following news release:
* * *
UCLA researchers discover new approach for treating autism and conditions caused by a single faulty gene copy
Early-stage study in human cell models points to a possible new approach for conditions caused by a single faulty gene copy
November 13, 2026
Researchers at UCLA Health have shown in lab-grown human brain cells that boosting the activity of a healthy gene copy can offset the effects of a mutation linked to autism.
The findings (https://www.nature.com/articles/s41593-026-02504-9?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20261113&utm_content=10.1038/s41593-026-02504-9),published in Nature Neuroscience, suggest a new direction for treating autism and related neurodevelopmental conditions, though the work is still at an early stage.
Autism is highly heritable, and roughly 15% of its genetic risk comes from new mutations that appear for the first time in a child rather than being inherited from a parent. Many of these mutations disable one of the two copies of a gene. Because a single working copy often cannot produce enough of the gene's product on its own, neurodevelopment can be altered. Most current autism treatments address symptoms resulting from these genetic mutations rather than underlying biology.
The UCLA team, led by Dr. Daniel Geschwind, focused on two genes strongly tied to autism, CHD8 and SCN2A. CHD8 helps regulate other genes involved in brain development, while SCN2A is essential for neurons to fire electrical signals.
Rather than replacing or editing the faulty gene, the researchers used a modified form of CRISPR to switch up the activity of the remaining healthy copy. They aimed it at enhancers, stretches of DNA that act like dials controlling when and how strongly a gene is expressed and often in a cell-type specific manner. Targeting these dials, instead of the gene itself, was intended to keep the gene's activity in step with natural brain development and to avoid overshooting into harmful overexpression of the gene.
"Many autism-linked mutations leave a person with one working copy of a gene instead of two," said Geschwind, the Gordon and Virginia MacDonald distinguished professor of Human Genetics, Neurology and Psychiatry at UCLA. "Our results show that, in human cell models, it's possible to turn up that remaining copy and move cells back toward typical development. This is a key first step, and it gives us a new way to think about addressing the biology underlying these conditions."
The team tested the approach in two kinds of human stem cell-derived models: cultures of excitatory neurons and cortical organoids, which are small clusters of brain-like tissue that mimic aspects of early brain development and key characteristics of neurodevelopmental disorders also seen in affected individuals.
Key findings included:
* In CHD8 models, boosting the healthy copy reduced abnormal organoid overgrowth and helped cells mature, and shifted gene activity closer to typical levels.
* In SCN2A models, the treatment restored much of the neurons' normal electrical activity, although some finer electrical properties normalized only in certain cell lines.
* The effect appeared only in cells carrying the mutation. Healthy cells showed no increase in gene activity, and neighboring genes were not affected.
* The timing of treatment mattered, suggesting the approach may work best at specific stages of development.
"What stands out to us is that the approach acted only in cell lines carrying the mutation and left healthy cell lines alone," said the study's first author George Chen, a former postdoctoral fellow in the Geschwind lab and current assistant professor of neurology at Children's Hospital of Los Angeles. "That kind of specificity matters for any future therapy. We are still a long way from the clinic, and there is a lot of work ahead on delivery and timing, but these findings provide hope and give us a clear direction."
The authors emphasize that the work was done entirely in lab models and that the extent of a shift from mutant to normal levels of expression varied between cell lines, so it is a proof of concept rather than a ready-to-use treatment. Delivering the approach safely to the brain requires improved delivery methods and testing whether it can work after the early developmental window has passed. As the strategy depends on a healthy gene copy, this approach is expected to broadly extend to other neurodevelopmental conditions caused by a single faulty copy of a gene.
* * *
Original text here: https://www.uclahealth.org/news/release/ucla-researchers-discover-new-approach-treating-autism-and
[Category: Medical]
Senior Environmental and Natural Resources Attorney Craig Galli Joins Dorsey in Salt Lake City
MINNEAPOLIS, Minnesota, Nov. 14 -- Dorsey and Whitney, a law firm, issued the following news:
* * *
Senior Environmental and Natural Resources Attorney Craig Galli Joins Dorsey in Salt Lake City
November 13, 2026
Craig Galli has joined Dorsey & Whitney LLP as Senior Counsel in the Regulatory Affairs group in Salt Lake City, the international law firm announced today.
Craig defends companies facing high-profile civil and criminal environmental enforcement actions and citizen suits, and advises companies in complex regulatory compliance issues involving the National Environmental Policy Act
... Show Full Article
MINNEAPOLIS, Minnesota, Nov. 14 -- Dorsey and Whitney, a law firm, issued the following news:
* * *
Senior Environmental and Natural Resources Attorney Craig Galli Joins Dorsey in Salt Lake City
November 13, 2026
Craig Galli has joined Dorsey & Whitney LLP as Senior Counsel in the Regulatory Affairs group in Salt Lake City, the international law firm announced today.
Craig defends companies facing high-profile civil and criminal environmental enforcement actions and citizen suits, and advises companies in complex regulatory compliance issues involving the National Environmental Policy Act(NEPA) and Clean Water Act aquatic resources protections. A former Senior Trial Attorney with the U.S. Department of Justice (DOJ) in Washington, D.C., Craig has taken more than 50 litigation matters to judgment. His clients include companies in mining, energy, water supply infrastructure, transportation, defense, land development, and manufacturing industries, and he advises on environmental due diligence for mining, renewable energy, electric transmission, and carbon sequestration projects. Craig also helps corporate clients strengthen their compliance programs, including compliance audit procedures, training, and environmental, social, and governance (ESG) reporting, and conducts internal investigations of alleged environmental crimes. Recognized as a leader in the field, Craig frequently speaks at professional conferences on environmental law and corporate compliance.
Craig joins Dorsey from Holland & Hart. Craig received his J.D. from Columbia University and his M.A. and B.A. from Brigham Young University.
"Craig adds exceptional depth of experience and strategic counsel to both our Regulatory Affairs team and our environmental litigation capabilities in Salt Lake City," said Megan Houdeshel, Regulatory Affairs Practice Group Leader for Dorsey. "Drawing on his tenure with the U.S. Department of Justice, he is well positioned to guide clients through environmental enforcement matters and complex regulatory compliance challenges across the energy, natural resources, and other highly regulated sectors."
"Dorsey has built a premier Regulatory Affairs practice known for tackling some of the most complex challenges facing clients today," said Craig. "I'm excited to bring my experience to the team and help clients navigate enforcement, compliance, and regulatory matters in support of their business objectives."
* * *
Original text here: https://www.dorsey.com/news/senior-environmental-and-natural-resources-attorney-craig-galli-joins-dorsey-in-salt-lake-city
[Category: BizLaw/Legal]
Newmark Group: Joint Venture Sells 250-Unit High-Rise Apartment Community in Denver's Golden Triangle
NEW YORK, Nov. 14 -- Newmark Group, a commercial real estate company that says they offer comprehensive suite of services and products, posted the following news release:
* * *
Joint Venture Sells 250-Unit High-Rise Apartment Community in Denver's Golden Triangle
November 12, 2026
A joint venture of Rockefeller Group and Summit Capital Venture Partners has sold Patten Gray, a 250-unit high-rise apartment community located at 370 W. 12th Avenue in Denver's Golden Triangle neighborhood. Newmark Managing Directors Courtney Crowder and Jack Kachadurian represented the seller in the transaction.
... Show Full Article
NEW YORK, Nov. 14 -- Newmark Group, a commercial real estate company that says they offer comprehensive suite of services and products, posted the following news release:
* * *
Joint Venture Sells 250-Unit High-Rise Apartment Community in Denver's Golden Triangle
November 12, 2026
A joint venture of Rockefeller Group and Summit Capital Venture Partners has sold Patten Gray, a 250-unit high-rise apartment community located at 370 W. 12th Avenue in Denver's Golden Triangle neighborhood. Newmark Managing Directors Courtney Crowder and Jack Kachadurian represented the seller in the transaction.Weidner Apartment Homes acquired the property.
Completed in 2024, Patten Gray is a 13-story property featuring contemporary architecture, thoughtfully designed residences and a range of resident offerings. Community amenities include a 13th-floor rooftop sky deck and lounge, a resort-style saltwater pool and hot tub, a fitness center, outdoor sauna and dedicated coworking space. The property also includes enclosed parking and ground-floor retail occupied by Flora, a coffee and cocktail bar.
"The quality of Patten Gray, from its design and construction to its amenity offerings and location, distinguishes it within the Denver multifamily market," said Crowder. "New ownership is well-positioned to capitalize on the property's strong standing and continued appeal in one of the city's most desirable neighborhoods."
The property's central Denver location provides residents with convenient access to downtown Denver, Cherry Creek and the area's dining, nightlife and retail destinations. Nearby outdoor recreation options include the Cherry Creek Trail, Washington Park and Civic Center Park.
"We continue to see investor interest in well-located multifamily assets that offer a combination of quality, scale and access to established residential neighborhoods," said Kachadurian. "Patten Gray checked those boxes and generated interest as a newly delivered property in Denver's urban core."
* * *
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leading commercial real estate advisor and service provider to large institutional investors and other owners, global corporations and other occupiers, and lenders. Built with purpose and driven by excellence, Newmark's comprehensive platform is uniquely tailored to provide superior outcomes to clients. For the twelve months ended September 30, 2026, Newmark generated revenues of over $3.7 billion. As of September 30, 2026, Newmark and its business partners together operated from approximately 200 offices with 10,500 professionals across four continents. Learn more at nmrk.com or follow @newmark.
* * *
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company's business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.
* * *
Original text here: https://www.nmrk.com/insights/press-releases/joint-venture-sells-250-unit-high-rise-apartment-community-in-denvers-golden-triangle
[Category: BizReal Estate]
Fried Frank: Procter & Gamble Closes $4B Offering of Four Tranches of Notes
NEW YORK, Nov. 14 -- Fried, Frank, Harris, Shriver and Jacobson LLP, a law firm, issued the following news release:
* * *
Procter & Gamble Closes $4B Offering of Four Tranches of Notes
November 13, 2026
Fried Frank advised Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and Morgan Stanley & Co. LLC, as lead underwriters, in The Procter & Gamble Company's (Procter & Gamble) $4 billion offering of four tranches of notes: $750 million of 5.125% notes due October 30, 2031, $750 million of 5.300% notes due October 30, 2033, $1.25
... Show Full Article
NEW YORK, Nov. 14 -- Fried, Frank, Harris, Shriver and Jacobson LLP, a law firm, issued the following news release:
* * *
Procter & Gamble Closes $4B Offering of Four Tranches of Notes
November 13, 2026
Fried Frank advised Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and Morgan Stanley & Co. LLC, as lead underwriters, in The Procter & Gamble Company's (Procter & Gamble) $4 billion offering of four tranches of notes: $750 million of 5.125% notes due October 30, 2031, $750 million of 5.300% notes due October 30, 2033, $1.25billion of 5.450% notes due October 30, 2036 and $1.25 billion of 5.900% notes due October 30, 2056.
The company intends to use the proceeds from this offering for general corporate purposes.
Procter & Gamble is a global provider of consumer-packaged goods and owns many of the world's leading household brands including Bounty, Charmin, Crest, Gillette, Oral-B, Pampers, Tide and Vicks, among others.
Capital markets partners Daniel J. Bursky and Andrew B. Barkan led the Fried Frank team.
* * *
This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm's data policy page for further information.
* * *
Original text here: https://www.friedfrank.com/news-and-insights/procter-gamble-closes-4b-offering-of-four-tranches-of-notes-13258
[Category: BizLaw/Legal]
Fried Frank: Procter & Gamble Closes $352.2M Offering of Floating Rate Notes
NEW YORK, Nov. 14 -- Fried, Frank, Harris, Shriver and Jacobson LLP, a law firm, issued the following news release:
* * *
Procter & Gamble Closes $352.2M Offering of Floating Rate Notes
November 13, 2026
Fried Frank advised J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC and UBS Securities LLC, as underwriters, in The Procter & Gamble Company's (Procter & Gamble) $352.2 million offering of floating rate notes due November 2, 2076.
The company intends to use the proceeds from this offering for general corporate purposes.
Procter & Gamble is a global provider
... Show Full Article
NEW YORK, Nov. 14 -- Fried, Frank, Harris, Shriver and Jacobson LLP, a law firm, issued the following news release:
* * *
Procter & Gamble Closes $352.2M Offering of Floating Rate Notes
November 13, 2026
Fried Frank advised J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC and UBS Securities LLC, as underwriters, in The Procter & Gamble Company's (Procter & Gamble) $352.2 million offering of floating rate notes due November 2, 2076.
The company intends to use the proceeds from this offering for general corporate purposes.
Procter & Gamble is a global providerof consumer-packaged goods and owns many of the world's leading household brands including Bounty, Charmin, Crest, Gillette, Oral-B, Pampers, Tide and Vicks, among others.
Capital markets partners Daniel J. Bursky and Andrew B. Barkan led the Fried Frank team.
* * *
This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm's data policy page for further information.
* * *
Original text here: https://www.friedfrank.com/news-and-insights/procter-gamble-closes-352-2m-offering-of-floating-rate-notes-13259
[Category: BizLaw/Legal]
CentraCare - Benson Earns Acute Stroke Ready Hospital Designation
ST. CLOUD, Minnesota, Nov. 14 -- CentraCare Health issued the following news release:
* * *
CentraCare - Benson Earns Acute Stroke Ready Hospital Designation
November 12, 2026
CentraCare - Benson has earned designation as an Acute Stroke Ready Hospital (ASRH) through the Minnesota Department of Health's Minnesota Stroke System of Care.
The designation recognizes the hospital's preparedness to quickly identify, evaluate and provide initial treatment for patients experiencing a stroke. Timely care is especially important for stroke patients because rapid diagnosis and treatment can reduce the
... Show Full Article
ST. CLOUD, Minnesota, Nov. 14 -- CentraCare Health issued the following news release:
* * *
CentraCare - Benson Earns Acute Stroke Ready Hospital Designation
November 12, 2026
CentraCare - Benson has earned designation as an Acute Stroke Ready Hospital (ASRH) through the Minnesota Department of Health's Minnesota Stroke System of Care.
The designation recognizes the hospital's preparedness to quickly identify, evaluate and provide initial treatment for patients experiencing a stroke. Timely care is especially important for stroke patients because rapid diagnosis and treatment can reduce therisk of long-term disability and improve outcomes.
"This designation reflects our team's ongoing dedication to delivering safe, timely, and high-quality stroke care to the Benson area," said Melissa McGinty-Thompson, CentraCare - Benson Director of Operations. "I am proud of each and every team member who played a role in maintaining this designation. Their commitment to clinical excellence, teamwork, and continuous preparedness helps ensure that patients experiencing a stroke can receive the care they need quickly and close to home."
To achieve Acute Stroke Ready Hospital designation, hospitals are evaluated against nine criteria established by the Minnesota Department of Health. CentraCare - Benson participates in the Minnesota Stroke System of Care, a statewide system designed to improve stroke care by helping ensure patients receive the right care as quickly as possible.
* * *
Original text here: https://www.centracare.com/about-us/news-publications/media-releases/2026-news/benson-earns-acute-stroke-ready-designation/
[Category: BizHealth Care]
